Issue
Alert me when new journal issues are available via or via
Rho GTPases: potential candidates for anticancer therapy Salvador Aznar, Pilar Fernández-Valerón, Carolina Espina, Juan Carlos Lacal pages 181-191 Abstract | Full Text | Full-Text PDF (192 KB)
Editorial
Featuring the guest editor Juan Carlos Lacal pages 123-124 Full Text | Full-Text PDF (76 KB)
Perspectives on farnesyl transferase inhibitors in cancer therapy Julien Mazieres, Anne Pradines, Gilles Favre pages 159-167 Abstract | Full Text | Full-Text PDF (132 KB)
The IKK/NF-κB activation pathway—a target for prevention and treatment of cancer Florian R. Greten, Michael Karin pages 193-199 Abstract | Full Text | Full-Text PDF (117 KB)
Ceramide synthesis and metabolism as a target for cancer therapy C.Patrick Reynolds, Barry J. Maurer, Richard N. Kolesnick pages 169-180 Abstract | Full Text | Full-Text PDF (188 KB)
Green fluorescent protein as a tool to study epidermal growth factor receptor function Nandini Hayes, Elodie Howard-Cofield, William Gullick pages 129-135 Abstract | Full Text | Full-Text PDF (155 KB)
From Ras signalling to ChoK inhibitors: a further advance in anticancer drug design Ana Ramı́rez de Molina, Agustı́n Rodrı́guez-González, Juan Carlos Lacal pages 137-148 Abstract | Full Text | Full-Text PDF (331 KB)
Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone Paul Workman pages 149-157 Abstract | Full Text | Full-Text PDF (146 KB)
Anticancer research: a few hints for discovery of new targets Juan Carlos Lacal pages 125-127 Full Text | Full-Text PDF (63 KB)
Editorial Board page CO2 Full-Text PDF (36 KB)
Contents page iv Full-Text PDF (17 KB)
Volume Contents pages 201-202 Full-Text PDF (52 KB)
Author Index pages 203-204 Full-Text PDF (44 KB)
Subject Index pages 205-208 Full-Text PDF (73 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
